Business Description
Biotron Ltd
ISIN : AU000000BIT4
Description
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.79 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 7.2 | |||||
| 3-Year EPS without NRI Growth Rate | 7.2 | |||||
| 3-Year FCF Growth Rate | 7.2 | |||||
| 3-Year Book Growth Rate | -26.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 85.27 | |||||
| 9-Day RSI | 73.28 | |||||
| 14-Day RSI | 63.66 | |||||
| 6-1 Month Momentum % | -41.12 | |||||
| 12-1 Month Momentum % | 171.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.85 | |||||
| Quick Ratio | 3.85 | |||||
| Cash Ratio | 1.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | 0.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -110.59 | |||||
| ROA % | -90.7 | |||||
| ROIC % | -656.41 | |||||
| ROC (Joel Greenblatt) % | -1380.19 | |||||
| ROCE % | -156.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 37.5 | |||||
| EV-to-EBIT | -11.72 | |||||
| EV-to-EBITDA | -11.81 | |||||
| EV-to-FCF | -11.69 | |||||
| Earnings Yield (Greenblatt) % | -8.53 | |||||
| FCF Yield % | -8.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BITRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biotron Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.003 | ||
| Beta | -0.8 | ||
| Volatility % | 97.89 | ||
| 14-Day RSI | 63.66 | ||
| 14-Day ATR ($) | 0.000605 | ||
| 20-Day SMA ($) | 0.05632 | ||
| 12-1 Month Momentum % | 171.86 | ||
| 52-Week Range ($) | 0.0005 - 0.0845 | ||
| Shares Outstanding (Mil) | 902.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biotron Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biotron Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biotron Ltd Frequently Asked Questions
What is Biotron Ltd(BITRF)'s stock price today?
The current price of BITRF is $0.06. The 52 week high of BITRF is $0.08 and 52 week low is $0.00.
When is next earnings date of Biotron Ltd(BITRF)?
The next earnings date of Biotron Ltd(BITRF) is .
Does Biotron Ltd(BITRF) pay dividends? If so, how much?
Biotron Ltd(BITRF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers